Drug class review on triptans final report update 3

Triptans, also called serotonin 5-hydroxytryptamine (5-HT)(1B/1D) agonists, are used to treat migraine and certain other headaches. Comparing the clinical efficacy and adverse effects of the different triptans has been an area of considerable interest to researchers and patients, but is complex beca...

Full description

Bibliographic Details
Main Author: Helfand, Mark
Corporate Author: Oregon Health & Science University Evidence-based Practice Center
Other Authors: Peterson, Kim
Format: eBook
Language:English
Published: Portland, Or. Oregon Health & Science University, Evidence-Based Practice Center c2005, 2005
Series:Drug class reviews
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02072nam a2200301 u 4500
001 EB000943481
003 EBX01000000000000000737071
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
100 1 |a Helfand, Mark 
245 0 0 |a Drug class review on triptans  |h Elektronische Ressource  |b final report update 3  |c Mark Helfand, Kim Peterson 
260 |a Portland, Or.  |b Oregon Health & Science University, Evidence-Based Practice Center  |c c2005, 2005 
300 |a PDF file (347 p.) 
505 0 |a Includes bibliographical references 
653 |a Drug Evaluation 
653 |a Clinical Trials as Topic 
653 |a Tryptamines / therapeutic use 
653 |a Headache Disorders / drug therapy 
700 1 |a Peterson, Kim 
710 2 |a Oregon Health & Science University  |b Evidence-based Practice Center 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Drug class reviews 
500 |a "November 2005.". - "The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK10715  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a Triptans, also called serotonin 5-hydroxytryptamine (5-HT)(1B/1D) agonists, are used to treat migraine and certain other headaches. Comparing the clinical efficacy and adverse effects of the different triptans has been an area of considerable interest to researchers and patients, but is complex because of the large variety of outcome measures that can be measured in studies. The purpose of this review is to compare the efficacy, effectiveness, and adverse effects of triptans